
Celebrity Announcements Of Breast Cancer Underscore Increasing Prevalence In Younger Women
Clinicians say the increasing incidence of breast cancer among younger women could be due to a combination of several factors, such as environmental, lifestyle and genetic factors. These rising cases make it more urgent to develop effective treatments against this disease. Entities like Calidi Biotherapeutics Inc. (NYSE American: CLDI) have taken on this...
Read More>>
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: /Disclaimer
BioMedWire
San Francisco, CA
415.949.5050 Office
[email protected]
BioMedWire is powered by IBN
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- B2BROKER Launches First-Ever Turnkey Liquidity Provider Solution
- Amboss Launches Rails: Empowering Bitcoin Yield And Lightning Network Growth
- B2PRIME Appoints Former Onezero Sales Head Stuart Brock As Institutional Business Development Manager
- My Funding Account Builds A Global Trader Community On Trust, Transparency, And Growth
- Young Entrepreneur Rayston Heem Launches Mentorship Program After Early Business Milestone
- Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
Comments
No comment